View in EDS

Evaluation of Protein Kinase cAMP-Activated Catalytic Subunit Alpha as a Therapeutic Target for Fibrolamellar Carcinoma.

Saved in:
Bibliographic Details
Title: Evaluation of Protein Kinase cAMP-Activated Catalytic Subunit Alpha as a Therapeutic Target for Fibrolamellar Carcinoma.
Authors: Schalm SS; Blueprint Medicines Corporation, Cambridge, Massachusetts., O'Hearn E; Blueprint Medicines Corporation, Cambridge, Massachusetts., Wilson K; Blueprint Medicines Corporation, Cambridge, Massachusetts., LaBranche TP; Blueprint Medicines Corporation, Cambridge, Massachusetts., Silva G; Blueprint Medicines Corporation, Cambridge, Massachusetts., Zhang Z; Blueprint Medicines Corporation, Cambridge, Massachusetts., DiPietro L; Blueprint Medicines Corporation, Cambridge, Massachusetts., Bifulco N; Blueprint Medicines Corporation, Cambridge, Massachusetts., Woessner R; Blueprint Medicines Corporation, Cambridge, Massachusetts., Stransky N; Blueprint Medicines Corporation, Cambridge, Massachusetts., Sappal D; Blueprint Medicines Corporation, Cambridge, Massachusetts., Campbell R; Blueprint Medicines Corporation, Cambridge, Massachusetts., Lobbardi R; Blueprint Medicines Corporation, Cambridge, Massachusetts., Palmer M; Blueprint Medicines Corporation, Cambridge, Massachusetts., Kim J; Blueprint Medicines Corporation, Cambridge, Massachusetts., Ye C; Blueprint Medicines Corporation, Cambridge, Massachusetts., Dorsch M; Blueprint Medicines Corporation, Cambridge, Massachusetts., Lengauer C; Blueprint Medicines Corporation, Cambridge, Massachusetts., Guzi T; Blueprint Medicines Corporation, Cambridge, Massachusetts., Kadambi V; Blueprint Medicines Corporation, Cambridge, Massachusetts., Garner A; Blueprint Medicines Corporation, Cambridge, Massachusetts., Hoeflich KP; Blueprint Medicines Corporation, Cambridge, Massachusetts.
Source: Gastro hep advances [Gastro Hep Adv] 2022 Nov 08; Vol. 2 (3), pp. 307-321. Date of Electronic Publication: 2022 Nov 08 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc on behalf of the AGA Institute Country of Publication: Netherlands NLM ID: 9918350485906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2772-5723 (Electronic) Linking ISSN: 27725723 NLM ISO Abbreviation: Gastro Hep Adv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39132655
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Evaluation of Protein Kinase cAMP-Activated Catalytic Subunit Alpha as a Therapeutic Target for Fibrolamellar Carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Schalm+SS%22">Schalm SS</searchLink>; Blueprint Medicines Corporation, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22O'Hearn+E%22">O'Hearn E</searchLink>; Blueprint Medicines Corporation, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Wilson+K%22">Wilson K</searchLink>; Blueprint Medicines Corporation, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22LaBranche+TP%22">LaBranche TP</searchLink>; Blueprint Medicines Corporation, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Silva+G%22">Silva G</searchLink>; Blueprint Medicines Corporation, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Zhang+Z%22">Zhang Z</searchLink>; Blueprint Medicines Corporation, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22DiPietro+L%22">DiPietro L</searchLink>; Blueprint Medicines Corporation, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Bifulco+N%22">Bifulco N</searchLink>; Blueprint Medicines Corporation, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Woessner+R%22">Woessner R</searchLink>; Blueprint Medicines Corporation, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Stransky+N%22">Stransky N</searchLink>; Blueprint Medicines Corporation, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Sappal+D%22">Sappal D</searchLink>; Blueprint Medicines Corporation, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Campbell+R%22">Campbell R</searchLink>; Blueprint Medicines Corporation, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Lobbardi+R%22">Lobbardi R</searchLink>; Blueprint Medicines Corporation, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Palmer+M%22">Palmer M</searchLink>; Blueprint Medicines Corporation, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Kim+J%22">Kim J</searchLink>; Blueprint Medicines Corporation, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Ye+C%22">Ye C</searchLink>; Blueprint Medicines Corporation, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Dorsch+M%22">Dorsch M</searchLink>; Blueprint Medicines Corporation, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Lengauer+C%22">Lengauer C</searchLink>; Blueprint Medicines Corporation, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Guzi+T%22">Guzi T</searchLink>; Blueprint Medicines Corporation, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Kadambi+V%22">Kadambi V</searchLink>; Blueprint Medicines Corporation, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Garner+A%22">Garner A</searchLink>; Blueprint Medicines Corporation, Cambridge, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Hoeflich+KP%22">Hoeflich KP</searchLink>; Blueprint Medicines Corporation, Cambridge, Massachusetts.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918350485906676%22">Gastro hep advances</searchLink> [Gastro Hep Adv] 2022 Nov 08; Vol. 2 (3), pp. 307-321. <i>Date of Electronic Publication: </i>2022 Nov 08 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc+on+behalf+of+the+AGA+Institute%22">Elsevier Inc on behalf of the AGA Institute </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>9918350485906676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2772-5723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2227725723%22">27725723 </searchLink><i>NLM ISO Abbreviation: </i>Gastro Hep Adv <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39132655
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.gastha.2022.11.004
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 307
    Titles:
      – TitleFull: Evaluation of Protein Kinase cAMP-Activated Catalytic Subunit Alpha as a Therapeutic Target for Fibrolamellar Carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Schalm SS
      – PersonEntity:
          Name:
            NameFull: O'Hearn E
      – PersonEntity:
          Name:
            NameFull: Wilson K
      – PersonEntity:
          Name:
            NameFull: LaBranche TP
      – PersonEntity:
          Name:
            NameFull: Silva G
      – PersonEntity:
          Name:
            NameFull: Zhang Z
      – PersonEntity:
          Name:
            NameFull: DiPietro L
      – PersonEntity:
          Name:
            NameFull: Bifulco N
      – PersonEntity:
          Name:
            NameFull: Woessner R
      – PersonEntity:
          Name:
            NameFull: Stransky N
      – PersonEntity:
          Name:
            NameFull: Sappal D
      – PersonEntity:
          Name:
            NameFull: Campbell R
      – PersonEntity:
          Name:
            NameFull: Lobbardi R
      – PersonEntity:
          Name:
            NameFull: Palmer M
      – PersonEntity:
          Name:
            NameFull: Kim J
      – PersonEntity:
          Name:
            NameFull: Ye C
      – PersonEntity:
          Name:
            NameFull: Dorsch M
      – PersonEntity:
          Name:
            NameFull: Lengauer C
      – PersonEntity:
          Name:
            NameFull: Guzi T
      – PersonEntity:
          Name:
            NameFull: Kadambi V
      – PersonEntity:
          Name:
            NameFull: Garner A
      – PersonEntity:
          Name:
            NameFull: Hoeflich KP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 11
              Text: 2022 Nov 08
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2772-5723
          Numbering:
            – Type: volume
              Value: 2
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Gastro hep advances
              Type: main
ResultId 1